The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Christophe Van de Van de Wiele

Department of Nuclear Medicine (P7)

University Hospital Ghent

De Pintelaan 185B

9000, Ghent

Belgium

[email]@ugent.be

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Nuclear Medicine (P7), University Hospital Ghent, De Pintelaan 185B, 9000, Ghent, Belgium. 2004 - 2012

References

  1. SIRT of liver metastases: physiological and pathophysiological considerations. Van de Wiele, C., Maes, A., Brugman, E., D'Asseler, Y., De Spiegeleer, B., Mees, G., Stellamans, K. Eur. J. Nucl. Med. Mol. Imaging (2012) [Pubmed]
  2. Radioembolization of hepatocellular carcinoma. Van de Wiele, C. Curr. Drug. Discov. Technol (2010) [Pubmed]
  3. Yttrium-90 labelled resin microspheres for treatment of primary and secondary malignant liver tumors. Van De Wiele, C., Defreyne, L., Peeters, M., Lambert, B. Q. J. Nucl. Med. Mol. Imaging (2009) [Pubmed]
  4. Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry. Van de Wiele, C., Phonteyne, P., Pauwels, P., Goethals, I., Van den Broecke, R., Cocquyt, V., Dierckx, R.A. J. Nucl. Med. (2008) [Pubmed]
  5. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels. Van de Wiele, C., VandeVyver, F., Debruyne, C., Philippé, J., van Meerbeeck, J.P. Eur. J. Nucl. Med. Mol. Imaging (2008) [Pubmed]
  6. Growth factor/peptide receptor imaging for the development of targeted therapy in oncology. Van de Wiele, C., Boersma, H., Dierckx, R.A., De Spiegeleer, B., Van Waarde, A., Elsinga, P.H. Curr. Pharm. Des. (2008) [Pubmed]
  7. Imaging probes targeting matrix metalloproteinases. Van de Wiele, C., Oltenfreiter, R. Cancer Biother. Radiopharm. (2006) [Pubmed]
  8. 99mTc-Hynic-Annexin V. North American Scientific. Van de Wiele, C. IDrugs (2004) [Pubmed]
  9. Radiolabeled annexin-V for monitoring treatment response in oncology. Van de Wiele, C., Vermeersch, H., Loose, D., Signore, A., Mertens, N., Dierckx, R. Cancer Biother. Radiopharm. (2004) [Pubmed]
  10. Radioimmunoimaging. Advances and prospects. Van de Wiele, C., Revets, H., Mertens, N. Quarterly J. Nuclear Medicine Molecular Imaging : Official Publication Italian Association Nuclear Medicine (aimn) [and] International Association Radiopharmacology (iar), [and] Section Society Radiopharmaceut... (2004) [Pubmed]
  11. The 17th International IRIST Congress Proceedings. Wiele, C.V., Signore, A. Cancer Biother. Radiopharm. (2004) [Pubmed]
 
WikiGenes - Universities